The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

Earlier blood-test detection could help identify pancreatic cancer patients who need more aggressive treatment, an expert ...

The ultra-sensitive test can find hidden signs of pancreatic cancer by looking for a key KRAS genetic mutation missed by ...

Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit ...

The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are ...

A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska ...

A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...

A pioneering blood test detected more than twice as many high-risk prostate cancer cases as current methods, paving the way for more effective screening.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group ...

More patients in primary care practices with vs. without access to a blood-based lung cancer screening test received ...